RNVA — Rennova Health Cashflow Statement
0.000.00%
Last trade - 00:00- $0.04m
- $11.39m
- $18.69m
- 56
- 99
- 17
- 59
Annual cashflow statement for Rennova Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | C2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -45.2 | -16.4 | -5.27 | -3.27 | -0.554 |
| Depreciation | |||||
| Non-Cash Items | 15.1 | -11.2 | -8.73 | -0.974 | 0.954 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 15.8 | 9.94 | 4.44 | 3.56 | 2.68 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -13.5 | -16.9 | -8.91 | -0.218 | 3.39 |
| Capital Expenditures | -0 | -0.371 | — | -0.035 | -0.351 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.659 | 0.082 | -0.374 | -0.87 | -1.18 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.659 | -0.289 | -0.374 | -0.905 | -1.53 |
| Financing Cash Flow Items | -0.452 | 13 | 0.464 | -0.404 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.2 | 17.2 | 9.99 | 0.898 | -2.31 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.015 | 0.008 | 0.699 | -0.225 | -0.45 |